Figures computed from official regulatory filings — .
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for CEREBAIN BIOTECH CORP. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Business description unavailable in our sources.
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
4 buysbar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Tate Wesley D. | Award | $28.8K | SEC | ||
| Award |
| $28.8K |
| SEC |
| CLEMONS ERIC | Award | $40.5K | SEC |
| Tate Wesley D. | Award | $45K | SEC |
| Tate Wesley D. | Award | $40.5K | SEC |
| Tate Wesley D. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Tate Wesley D. | Award | $77.5K | SEC |
| CLEMONS ERIC | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| CLEMONS ERIC | Award | $1.4B | Unusual size | SEC |
| CLEMONS ERIC | Award | $77.5K | SEC |
| CLEMONS ERIC | Award | $72.7K | Unusual size | SEC |
| CLEMONS ERIC | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| CLEMONS ERIC | Buy | $121K | conv 74First in 12mo | SEC |
| Tate Wesley D. | Buy | $51.9K | conv 100First in 12mo | SEC |
| Tate Wesley D. | Buy | $37.5K | conv 83First in 12mo | SEC |
| Tate Wesley D. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| DECICCIO GERALD A | Buy | n/a (No price was disclosed in the filing) | conv 100First in 12mo | SEC |